Bayer
The German pharma giant is working with top eye hospitals in the country to support virtual care for patients with Diabetic Macular Edema or age-related macular degeneration.
Also, Ujala Cygnus opens an ICU telemedicine facility in New Delhi.
It's been quite a year for digital, from Akili's de novo clearance to the downfall of 'digital pill' maker Proteus. MobiHealthNews takes a look back at the highlights.
The data-driven blood glucose monitor system-maker will use the money to push into new areas of disease management, such as cardiology, oncology and women's health.
Panelists at Women of Wearable's FemTech Forum discuss how big data and digital tools could help booster female representation in clinical trials.
Bayer and Exscientia will initially work on three early-stage projects using AI to speed up drug discovery.
Sidekick was previously selected to take part in the German pharma and life sciences giant's G4A programme.
Leaps by Bayer led the round, bringing the company's total funding to $50 million.
These include Wellthy Therapeutics, from India; OKKO Health, from the UK; and Carepay, from Kenya.
The German firm will provide pharmaceutical insight in a consortium which aims to accelerate discovery and development of new medicines using clinical AI.